Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001082554-05-000147
Filing Date
2005-12-02
Accepted
2005-12-02 21:31:52
Documents
1
Period of Report
2005-12-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7206
  Complete submission text file 0001082554-05-000147.txt   9002
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address C/O UNITED THERAPEUTICS CORP 1110 SPRING STREET SILVER SPRING MD 20910 3016089292
HADEED FRED T (Reporting) CIK: 0001231612 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 051242640